Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
SURGERY	O
Allergies:	O
Patient	O
recorded	O
as	O
having	O
No	O
Known	O
Allergies	O
to	O
Drugs	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Bilateral	O
lower	O
extremity	O
ulcers	B-Pressure_injury
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Debridement	O
of	O
L	O
ankle	O
ulcer	B-Pressure_injury
left	O
lower	O
extremity	O
angiograms,	O
Bilateral	O
Common	O
Iliac	O
Artery	O
stent	O
placement	O
History	O
of	O
Present	O
Illness:	O
___	O
y/o	O
M	O
with	O
h/o	O
of	O
DM,	O
and	O
subdural	B-Intracranial_haemorrhage
hematoma	B-Intracranial_haemorrhage
now	O
presents	O
from	O
referring	O
institution	O
with	O
non-healing	O
ulcers	B-Pressure_injury
of	O
bilateral	O
ankles.	O
Patient	O
was	O
admitted	O
to	O
the	O
outside	O
hospital	O
for	O
confusion	B-Delirium
and	O
presumed	O
pneumonitis.	B-Lower_respiratory_tract_infection
Initial	O
WBC	O
was	O
16K.	O
BCx	O
and	O
UCx	O
showed	O
No	O
growth	O
but	O
___	O
of	O
wound	O
swab	O
showed	O
3+	O
GPC	O
aand	O
3+	O
GNR.	O
Head	B-Intracranial_haemorrhage
CT	O
showed	O
no	O
acute	O
intracranial	B-Intracranial_haemorrhage
pathology	O
and	O
CXR	O
showed	O
possible	O
bibasilar	O
atelectasis.	O
Per	O
limited	O
transfer	O
documentation	O
patient	O
was	O
started	O
on	O
antibiotics	O
and	O
thought	O
to	O
be	O
stable	O
with	O
the	O
exception	O
of	O
chronic	O
bilateral	O
lower	O
extremity	O
wounds.	O
Patient	O
was	O
see	O
by	O
wound	O
care	O
started	O
on	O
clindamycin	O
for	O
progressive	O
cellulites	O
and	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
Micro	O
data	O
from	O
the	O
referring	O
institution	O
revealed	O
2+	O
enterococcus	O
sensitive	O
Vancomycin,	O
gentamicin,	O
levofloxacin,	O
ampicillin	O
and	O
cefoxitin.	O
Past	O
Medical	O
History:	O
DM	O
HTN	O
Subdural	B-Intracranial_haemorrhage
Hematoma-old	B-Intracranial_haemorrhage
Depression	O
Neuropathy	O
CRI	O
Social	O
History:	O
___	O
Family	O
History:	O
N/C	O
Physical	O
Exam:	O
Vital	O
Signs:	O
Temp:	O
98.2	O
RR:	O
18	O
Pulse:	O
69	O
BP:	O
159/68	O
Neuro/Psych:	O
AAOx3,	B-Delirium
NAD	O
Neck:	O
No	O
masses,	O
Trachea	O
midline,	O
No	O
right	O
carotid	O
bruit,	O
No	O
left	O
carotid	O
bruit.	O
Nodes:	O
No	O
clavicular/cervical	O
adenopathy,	O
No	O
inguinal	O
adenopathy.	O
Heart:	O
Regular	O
rate	O
and	O
rhythm.	O
Lungs:	O
Normal	O
respiratory	O
effort.	O
Gastrointestinal:	O
Non	O
distended,	O
No	O
masses,	O
No	O
hernia.	O
Extremities:	O
warm	O
bilaterally.	O
Right	O
medial	O
maleolus-	O
dry	O
eschar.	O
Left	O
lateral	O
maleolus-w/	O
large	O
open	O
wound	O
s/p	O
debridement,	O
no	O
exudate,	O
no	O
drainage.	O
Pulse	O
Exam	O
(P=Palpation,	O
D=Dopplerable,	O
N=None)	O
RLE	O
Femoral:	O
P.	O
DP:	O
D.	O
___:	O
D.	O
LLE	O
Femoral:	O
P.	O
DP:	O
D.	O
___:	O
D.	O
Pertinent	O
Results:	O
___	O
05:25AM	O
BLOOD	O
WBC-15.0*	O
RBC-3.08*	O
Hgb-9.3*	O
Hct-29.1*	O
MCV-95	O
MCH-30.1	O
MCHC-31.8	O
RDW-14.5	O
Plt	O
___	O
___	O
07:00AM	O
BLOOD	O
WBC-16.2*	O
RBC-3.20*	O
Hgb-9.3*	O
Hct-29.8*	O
MCV-93	O
MCH-29.0	O
MCHC-31.1	O
RDW-14.5	O
Plt	O
___	O
___	O
05:25AM	O
BLOOD	O
Plt	O
___	O
___	O
07:00AM	O
BLOOD	O
Plt	O
___	O
___	O
05:25AM	O
BLOOD	O
Glucose-130*	O
UreaN-15	O
Creat-1.1	O
Na-144	O
K-4.6	O
Cl-105	O
HCO3-31	O
AnGap-13	O
___	O
03:35AM	O
BLOOD	O
ALT-55*	O
AST-40	O
AlkPhos-134*	O
TotBili-0.3	O
___	O
05:25AM	O
BLOOD	O
Calcium-8.4	O
Phos-3.1	O
Mg-1.9	O
Cardiology	O
Report	O
ECG	O
Study	O
Date	O
of	O
___	O
7:52:14	O
___	O
Sinus	O
tachycardia,	O
rate	O
103.	O
Otherwise,	O
normal	O
tracing.	O
No	O
previous	O
tracing	O
available	O
for	O
comparison.	O
Radiology	O
Report	O
ART	O
EXT	O
(REST	O
ONLY)	O
Study	O
Date	O
of	O
___	O
4:28	O
___	O
IMPRESSION:	O
Moderately	O
severe	O
bilateral	O
lower	O
extremity	O
occlusive	O
disease	O
with	O
SFA,	O
popliteal	O
and	O
tibial	O
occlusions	O
on	O
the	O
right	O
and	O
mild	O
iliac	O
and	O
moderately	O
severe	O
tibial	O
disease	O
on	O
the	O
left.	O
Right-sided	O
metatarsal	O
PVR	O
waveform	O
is	O
nearly	O
aphasic.	O
ANKLE	O
(2	O
VIEWS)	O
LEFT	O
Study	O
Date	O
of	O
___	O
4:52	O
___	O
There	O
is	O
significant	O
amount	O
of	O
subcutaneous	O
air	O
along	O
the	O
lateral	O
malleolus	O
and	O
distal	O
tibia.	O
There	O
is	O
also	O
soft	O
tissue	O
swelling.	O
There	O
is	O
questionable	O
bone	O
destruction	O
along	O
the	O
mid	O
aspect	O
of	O
the	O
lateral	O
malleolus	O
that	O
might	O
be	O
consistent	O
with	O
osteomyelitis,	O
although	O
the	O
findings	O
are	O
minimal	O
and	O
should	O
be	O
reevaluated	O
by	O
MRI	O
or	O
nuclear	O
scan.	O
There	O
are	O
degenerative	O
changes	O
of	O
the	O
calcaneus.	O
No	O
other	O
abnormality	O
is	O
demonstrated.	O
CHEST	O
(PA	O
&	O
LAT)	O
Study	O
Date	O
of	O
___	O
4:52	O
___	O
The	O
heart	O
size	O
is	O
top	O
normal.	O
Mediastinal	O
position,	O
contour	O
and	O
width	O
are	O
unremarkable.	O
Left	O
lung	O
is	O
essentially	O
clear.	O
In	O
the	O
right	O
lung	B-Lower_respiratory_tract_infection
base	O
there	O
is	O
a	O
opacity	O
obscuring	O
the	O
hemidiaphragm	O
with	O
elevation	O
of	O
the	O
right	O
hemidiaphragm,	O
that	O
is	O
continuing	O
with	O
the	O
hilus	O
and	O
might	O
represent	O
a	O
combination	O
of	O
atelectasis	O
and	O
infectious	B-Lower_respiratory_tract_infection
process.	O
Followup	O
of	O
the	O
patient	O
after	O
completion	O
of	O
antibiotic	O
therapy	O
is	O
recommended	O
for	O
documentation	O
of	O
resolution.	O
If	O
findings	O
persist	O
evaluation	O
with	O
chest	O
CT	O
might	O
be	O
considered	O
to	O
exclude	O
the	O
possibility	O
of	O
post-obstructive	O
pneumonia.	B-Lower_respiratory_tract_infection
Portable	O
TTE	O
(Complete)	O
Done	O
___	O
at	O
11:58:27	O
AM	O
FINAL	O
Conclusions	O
The	O
left	O
atrium	O
is	O
normal	O
in	O
size.	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
are	O
normal	O
(LVEF	O
>55%).	O
Regional	O
left	O
ventricular	O
wall	O
motion	O
is	O
normal.	O
The	O
estimated	O
cardiac	O
index	O
is	O
normal	O
(>=2.5L/min/m2).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
Trace	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Moderate	O
pulmonary	O
hypertension.	O
Normal	O
global	O
and	O
regional	O
biventricular	O
systolic	O
function.	O
ECG	O
Study	O
Date	O
of	O
___	O
3:07:04	O
AM	O
Atrial	O
fibrillation	O
with	O
rapid	O
ventricular	O
response.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
atrial	O
fibrillation	O
has	O
appeared.	O
There	O
is	O
delayed	O
precordial	O
R	O
wave	O
transition.	O
VENOUS	O
DUP	O
EXT	O
UNI	O
(MAP/DVT)	O
Study	O
Date	O
of	O
___	O
3:47	O
___	O
FINDINGS:	O
RIGHT:	O
The	O
right	O
greater	O
saphenous	O
vein	O
is	O
patent	O
with	O
diameters	O
from	O
ankle	O
to	O
knee	O
of	O
2.6,	O
2.8,	O
3.7,	O
4.1.	O
Diameters	O
from	O
knee	O
to	O
groin	O
are	O
3.6,	O
3.7,	O
4.6	O
mm	O
respectively.	O
LEFT:	O
The	O
left	O
greater	O
saphenous	O
is	O
patent.	O
Diameters	O
from	O
ankle	O
to	O
knee	O
are	O
4.6,	O
3.3,	O
3.2,	O
4.0,	O
3.5	O
mm.	O
From	O
the	O
knee	O
to	O
the	O
groin	O
the	O
diameters	O
are	O
3.7,	O
3.2,	O
3.1,	O
6.2	O
mm.	O
IMPRESSION:	O
Patent	O
bilateral	O
greater	O
saphenous	O
veins	O
with	O
diameters	O
as	O
noted	O
above.	O
Brief	O
Hospital	O
Course:	O
___	O
Patient	O
was	O
transfered	O
to	O
___	O
surgery	O
from	O
OSH	O
for	O
left	O
lateral	O
ankle	O
and	O
right	O
medial	O
ankle	O
non-healing	O
ulcers.	O
Started	O
on	O
broad	O
spectrum	O
antibiotics	O
(Vanco/Cipro/Flagyl).	O
Routine	O
nursing,	O
labs	O
and	O
wound	O
care.	O
Foot	O
x-rays-bone	O
destruction	O
along	O
mid	O
aspect	O
of	O
lateral	O
maleolus	O
c/w	O
osteomyelitis.	O
NIAS-	O
was	O
done,	O
showed	O
bilateral	O
lower	O
extremity	O
occlusive	O
disease	O
with	O
SFA,	O
popliteal	O
and	O
tibial	O
occlusions	O
on	O
the	O
right	O
and	O
mild	O
iliac	O
and	O
moderately	O
severe	O
tibial	O
disease	O
on	O
the	O
left.	O
Right-sided	O
metatarsal	O
PVR	O
waveform	O
is	O
nearly	O
aphasic.	O
CXR	O
-right	O
lung	B-Lower_respiratory_tract_infection
base	O
there	O
is	O
a	O
opacity	O
obscuring	O
the	O
hemidiaphragm	O
with	O
elevation	O
of	O
the	O
right	O
hemidiaphragm,	O
that	O
is	O
continuing	O
with	O
the	O
hilus	O
and	O
might	O
represent	O
a	O
combination	O
of	O
atelectasis	O
and	O
infectious	B-Lower_respiratory_tract_infection
process.	O
On	O
admission	O
patient's	O
WBC	O
was	O
elevated,	O
blood	O
cultures	O
were	O
sent.	O
___	O
Patient	O
had	O
debridement	O
of	O
the	O
left	O
lateral	O
ulcer,	B-Pressure_injury
cultures	O
were	O
sent.	O
Continued	O
on	O
broad	O
spectrum	O
antibiotics,	O
and	O
wound	O
care.	O
Blood	O
cultures	O
came	O
back	O
negative.	O
Continued	O
to	O
trend	O
___'s.	O
___	O
Patient	O
continued	O
on	O
antibiotics,	O
wound	O
care.	O
Patient	O
went	O
into	O
atrial	O
fibrillation-new	O
onset	O
for	O
patient,	O
confirmed	O
by	O
ECG.	O
patient	O
was	O
placed	O
on	O
Diltizem	O
drip	O
ovenright,	O
converted	O
to	O
NSR	O
the	O
next	O
day.	O
Cardiology	O
consulted-recs	O
to	O
d/c	O
Diltiazem	O
and	O
start	O
low	O
dose	O
Lopressor	O
PO,	O
to	O
titrate	O
up	O
w/	O
goal	O
HR	O
of	O
60-80	O
BPM.	O
Patient	O
was	O
pre-oped	O
and	O
consented	O
for	O
BLE	O
angiograms.	O
made	O
NPO	O
post	O
MN	O
and	O
IV	O
hydrated.	O
___	O
Patient	O
was	O
taken	O
to	O
angio	O
suite	O
and	O
underwent	O
B/L	O
___	O
angiograms	O
w/	O
bilateral	O
common	O
iliac	O
artery	O
stent	O
placement.	O
Detremined	O
to	O
need	O
R	O
Fem-pop	O
bypass	O
in	O
the	O
future.	O
Patient	O
recovered	O
then	O
transferred	O
back	O
to	O
floor,	O
was	O
on	O
bedrest	O
for	O
the	O
prescribed	O
amount	O
of	O
time.	O
PO	O
meds	O
and	O
diet	O
resumed,	O
post	O
hydration	O
was	O
also	O
given.	O
Continued	O
w/	O
wound	O
care.	O
___	O
No	O
acute	O
events.	O
Continued	O
to	O
trend	O
___'s.	O
Wound	O
cultures	O
came	O
back	O
Staph	O
coag	O
+	O
sensitive	O
to	O
most	O
antibiotics	O
inclusing	O
Bactrim.	O
Switched	O
antibiotics	O
to	O
Bactrim.	O
Physical	O
therapy	O
consult-recs	O
d/c	O
to	O
rehab.	O
Rehab	O
screening	O
requested.	O
___	O
No	O
acute	O
events,	O
awaiting	O
placement.	O
___	O
Discharged	O
to	O
extended	O
care	O
facility	O
in	O
good	O
condition.	O
Will	O
be	O
re-admitted	O
early	O
next	O
week	O
for	O
bypass	O
surgery.	O
Patient	O
will	O
call	O
Dr.	O
___	O
for	O
details	O
of	O
admission.	O
Medications	O
on	O
Admission:	O
Gabapentin	O
400	O
mg	O
po	O
qd	O
Novolog	O
SS	O
Lantus	O
15u	O
qhs	O
Lispro	O
20u	O
qAM	O
and	O
30u	O
qPM	O
Lisinopril	O
5	O
mg	O
qd	O
Mirtazipine	O
15	O
mg	O
po	O
qd	O
Phynetoin	O
130	O
mg	O
po	O
qd	O
Trazodone	O
50	O
qhs	O
Ativan	O
1	O
prn	O
Discharge	O
Medications:	O
1.	O
Clopidogrel	O
75	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily)	O
for	O
1	O
months:	O
no	O
refill.	O
Disp:*30	O
Tablet(s)*	O
Refills:*0*	O
2.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
Tablet	O
Sig:	O
1.5	O
Tablets	O
PO	O
TID	O
(3	O
times	O
a	O
day):	O
goal	O
HR	O
60-80.	O
3.	O
Acetaminophen	O
500	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
4.	O
Lisinopril	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
Mirtazapine	O
15	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
6.	O
Phenytoin	O
Sodium	O
Extended	O
Oral	O
7.	O
Trazodone	O
50	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
8.	O
Aspirin	O
325	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
DAILY	O
(Daily).	O
9.	O
Gabapentin	O
400	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
DAILY	O
(Daily).	O
10.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
11.	O
Oxycodone	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q4H	O
(every	O
4	O
hours)	O
as	O
needed	O
for	O
pain.	O
12.	O
Humalog	O
sliding	O
scale	O
Breakfast	O
Lunch	O
Dinner	O
Bedtime	O
Glucose	O
Insulin	O
Dose	O
___	O
mg/dL	O
Proceed	O
with	O
hypoglycemia	O
protocol	O
Proceed	O
with	O
hypoglycemia	O
protocol	O
Proceed	O
with	O
hypoglycemia	O
protocol	O
Proceed	O
with	O
hypoglycemia	O
protocol	O
71-100	O
mg/dL	O
0	O
Units	O
0	O
Units	O
0	O
Units	O
0	O
Units	O
101-120	O
mg/dL	O
2	O
Units	O
2	O
Units	O
2	O
Units	O
2	O
Units	O
121-140	O
mg/dL	O
4	O
Units	O
4	O
Units	O
4	O
Units	O
4	O
Units	O
141-160	O
mg/dL	O
6	O
Units	O
6	O
Units	O
6	O
Units	O
6	O
Units	O
161-180	O
mg/dL	O
8	O
Units	O
8	O
Units	O
8	O
Units	O
8	O
Units	O
181-200	O
mg/dL	O
10	O
Units	O
10	O
Units	O
10	O
Units	O
10	O
Units	O
201-220	O
mg/dL	O
12	O
Units	O
12	O
Units	O
12	O
Units	O
12	O
Units	O
221-240	O
mg/dL	O
14	O
Units	O
14	O
Units	O
14	O
Units	O
14	O
Units	O
241-260	O
mg/dL	O
16	O
Units	O
16	O
Units	O
16	O
Units	O
16	O
Units	O
261-280	O
mg/dL	O
18	O
Units	O
18	O
Units	O
18	O
Units	O
18	O
Units	O
281-300	O
mg/dL	O
20	O
Units	O
20	O
Units	O
20	O
Units	O
20	O
Units	O
>	O
300	O
mg/dL	O
___	O
M.D.	O
___	O
M.D.	O
___	O
M.D.	O
___	O
M.D.	O
13.	O
Glargine	O
Sig:	O
Fifteen	O
(15)	O
units	O
subcuatneous	O
injection	O
at	O
bedtime.	O
14.	O
Trimethoprim-Sulfamethoxazole	O
160-800	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
15.	O
Heparin	O
(Porcine)	O
5,000	O
unit/mL	O
Solution	O
Sig:	O
One	O
(1)	O
Injection	O
TID	O
(3	O
times	O
a	O
day).	O
16.	O
Glucagon	O
(Human	O
Recombinant)	O
1	O
mg	O
Recon	O
Soln	O
Sig:	O
One	O
(1)	O
Recon	O
Soln	O
Injection	O
Q15MIN	O
()	O
as	O
needed	O
for	O
hypoglycemia	O
protocol.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Bilateral	O
lower	O
extremity	O
ulcers-s/p	B-Pressure_injury
left	O
debridement-	O
for	O
dressing	O
TID	O
w/	O
NS	O
wet-dry	O
History	O
of:	O
DM	O
HTN	O
Subdural	B-Intracranial_haemorrhage
Hematoma-old	B-Intracranial_haemorrhage
Peripheral	O
Neuropathy	O
CRI	O
PSH:	O
Craniotomy	O
Discharge	O
Condition:	O
Mental	O
Status:Clear	I-Delirium
and	B-Delirium
coherent	B-Delirium
Level	O
of	O
Consciousness:Alert	O
and	O
interactive	O
Activity	O
Status:Ambulatory	I-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane)	O
Discharge	O
Instructions:	O
-	O
You	O
were	O
admitted	O
for	O
a	O
bilateral	O
lower	O
extremity	O
non-healing	O
ulcers.	B-Pressure_injury
large	O
left	O
lateral	O
and	O
right	O
medial	O
maleolus	O
areas,	O
-	O
The	O
left	O
ulcer	B-Pressure_injury
was	O
debrided,	O
now	O
needing	O
wet	O
to	O
dry	O
dressings	O
TID,	O
the	O
right	O
is	O
dry.	O
-	O
You	O
also	O
underwent	O
angiogram	O
and	O
had	O
bilateral	O
common	O
iliac	O
artery	O
stents	O
placed,	O
-	O
You	O
were	O
placed	O
on	O
Plavix	O
and	O
will	O
stay	O
on	O
it	O
for	O
1	O
month,	O
-	O
You	O
will	O
be	O
scheduled	O
for	O
Right	O
Fem-pop	O
artery	O
bypass	O
next	O
week	O
-	O
Continue	O
all	O
medications	O
including	O
Bactrim,	O
until	O
you	O
come	O
back	O
for	O
admission	O
next	O
week,	O
-	O
You	O
may	O
shower,	O
keep	O
the	O
left	O
foot	O
dry,	O
-	O
Regular	O
diet,	O
-	O
Activity	O
as	O
tolerated,	O
-	O
Call	O
Dr.	O
___	O
for	O
details	O
of	O
your	O
upcoming	O
bypass	O
surgery.	O
Followup	O
Instructions:	O
___	O

